Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jul 28, 2008; 14(28): 4558-4561
Published online Jul 28, 2008. doi: 10.3748/wjg.14.4558
Table 1 Clinical features of patients in HTG and control groups
HTG group (n = 45)Control group (n = 131)
Sex (Male/Female)27/1872/59
Age (mean ± SD, yr)40.8 ± 9.3 (24-61)a52.6 ± 13.4 (22-82)
Etiology, n (%)
Overeating and high fat diet18 (40.0)a19 (14.5)
Alcohol abuse21 (46.7)b31 (23.7)
Gallstones5 (11.1)b37 (28.2)
L-Asparaginase chemotherapy2 (4.4)0
Pregnancy6 (13.3)0
Underlying diseases, n (%)
Hypertension6 (13.3)15 (11.5)
Coronary heart disease3 (6.7)7 (5.3)
Atherosclerosis3 (6.7)9 (6.9)
Familial hyperlipidemia6 (13.3)11 (8.4)
Admission biochemical
Serum glucose (mmol/L)17.7 ± 7.7b13.4 ± 6.1
Hypoalbuminaemia (%)38 (84.4)b79 (60.3)
Hypocalcaemia (%)39 (86.7)b83 (63.4)
Hypopotassemia (%)16 (35.6)50 (38.2)
Hyponatremia (%)26 (57.8)59 (45.0)
Ranson’s score (mean ± SD)4.7 ± 1.94.9 ± 2.0
24-h APACHE II score (mean ± SD)13.6 ± 5.7b10.7 ± 4.6
Balthazar’s CT score (mean ± SD)5.4 ± 2.36.3 ± 5.4
Table 2 Incidence of complications and mortality in HTG and control groups n (%)
HTG group (n = 45)Control group ( n = 131)
Complications
ARDS29 (64.4)61 (46.6)
Renal failure23 (51.1)b22 (16.8)
Acute hepatitis20 (44.4)38 (29.0)
Shock17 (37.9)b19 (14.5)
Encephalopathy10 (22.2)24 (18.3)
Infection17 (37.4)b24 (18.3)
Death14 (31.1)b12 (9.1)